Exosomes from human cardiac progenitor cells for therapeutic applications: Development of a GMP-grade manufacturing method

Frontiers in Physiology

Volumn 9, Issue AUG, 2018, Pages

  Andriolo, Gabriella ^a,b   Provasi, Elena ^a,b   Lo Cicero, Viviana ^a,b   Brambilla, Andrea ^a,b   Soncin, Sabrina ^a,b   Torre, Tiziano ^a   Milano, Giuseppina ^a,b,c   Biemmi, Vanessa ^a,b   Vassalli, Giuseppe ^a,b   Turchetto, Lucia ^a,b   Barile, Lucio ^a,b   Radrizzani, Marina ^a,b  

^a DIVISION OF CARDIOLOGY   (Switzerland)

^b Swiss Institute for Regenerative Medicine   (Switzerland)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Cardiac progenitor cells; Exosomes; Good manufacturing practices; Large scale production; Quality control

Indexed keywords

5' NUCLEOTIDASE; CD14 ANTIGEN; CD20 ANTIGEN; CD34 ANTIGEN; CD63 ANTIGEN; CD81 ANTIGEN; CD9 ANTIGEN; ENDOGLIN; HLA DR ANTIGEN; RECEPTOR TYPE TYROSINE PROTEIN PHOSPHATASE C; THY 1 MEMBRANE GLYCOPROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR MESP1; TRANSCRIPTION FACTOR TBX18; TRANSCRIPTION FACTOR TBX5; TUMOR SUSCEPTIBILITY GENE 101 PROTEIN; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; AGED; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARDIAC STEM CELL; CELL ISOLATION; CONTROLLED STUDY; CROSSFLOW FILTRATION; EXOSOME; FEMALE; GOOD MANUFACTURING PRACTICE; HEART FUNCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MESENCHYMAL STEM CELL; MESODERMAL CELL; NONHUMAN; PROTEIN EXPRESSION; RAT; STEM CELL CULTURE; STEM CELL TRANSPLANTATION; XENO-FREE CULTURE;

EID: 85052244043     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2018.01169     Document Type: Article

References (34)

1. Barile, L., Cervio, E., Lionetti, V., Milano, G., Ciullo, A., Biemmi, V., et al. (2018). Cardioprotection by cardiac progenitor cell-secreted exosomes: role of pregnancy-associated plasma protein-A. Cardiovasc. Res. 114, 992-1005. doi: 10.1093/cvr/cvy055
2. Barile, L., Gherghiceanu, M., Popescu, L. M., Moccetti, T., and Vassalli, G. (2012). Ultrastructural evidence of exosome secretion by progenitor cells in adult mouse myocardium and adult human cardiospheres. J. Biomed. Biotechnol. 2012, 354605. doi: 10.1155/2012/354605
3. Barile, L., Lionetti, V., Cervio, E., Matteucci, M., Gherghiceanu, M., Popescu, L. M., et al. (2014). Extracellular vesicles from human cardiac progenitor cells inhibit cardiomyocyte apoptosis and improve cardiac function after myocardial infarction. Cardiovasc. Res. 103, 530-541. doi: 10.1093/cvr/cvu167
4. Barile, L., Milano, G., and Vassalli, G. (2017a). Beneficial effects of exosomes secreted by cardiac-derived progenitor cells and other cell types in myocardial ischemia. Stem Cell. Investig. 4:93. doi: 10.21037/sci.2017.11.06
5. Barile, L., Moccetti, T., Marban, E., and Vassalli, G. (2017b). Roles of exosomes in cardioprotection. Eur. Heart J. 38, 1372-1379. doi: 10.1093/eurheartj/ehw304
6. Barile, L., and Vassalli, G. (2017). Exosomes: therapy delivery tools and biomarkers of diseases. Pharmacol. Ther. 174, 63-78. doi: 10.1016/j.pharmthera.2017.02.020
7. Cervio, E., Barile, L., Moccetti, T., and Vassalli, G. (2015). Exosomes for intramyocardial intercellular communication. Stem Cells Int. 2015:482171. doi: 10.1155/2015/482171
8. De Couto, G., Gallet, R., Cambier, L., Jaghatspanyan, E., Makkar, N., Dawkins, J. F., et al. (2017). Exosomal microRNA transfer into macrophages mediates cellular postconditioning. Circulation 136, 200-214. doi: 10.1161/CIRCULATIONAHA.116.024590
9. European Pharmacopoeia. (2017). European Pharmacopoeia, 9th Edn. Strasbourg: European Directorate for the Quality of Medicines & HealthCare
10. Gallagher, J. M., Yamak, A., Kirilenko, P., Black, S., Bochtler, M., Lefebvre, C., et al. (2014). Carboxy terminus of GATA4 transcription factor is required for its cardiogenic activity and interaction with CDK4. Mech. Dev. 134, 31-41. doi: 10.1016/j.mod.2014.09.001
11. Gallet, R., Dawkins, J., Valle, J., Simsolo, E., De Couto, G., Middleton, R., et al. (2017). Exosomes secreted by cardiosphere-derived cells reduce scarring, attenuate adverse remodelling, and improve function in acute and chronic porcine myocardial infarction. Eur. Heart J. 38, 201-211. doi: 10.1093/eurheartj/ehw240
12. Gardiner, C., Di Vizio, D., Sahoo, S., Thery, C., Witwer, K. W., Wauben, M., et al. (2016). Techniques used for the isolation and characterization of extracellular vesicles: results of a worldwide survey. J Extracell. Vesicles 5:32945. doi: 10.3402/jev.v5.32945
13. Gouin, K., Peck, K., Antes, T., Johnson, J. L., Li, C., Vaturi, S. D., et al. (2017). A comprehensive method for identification of suitable reference genes in extracellular vesicles. J. Extracell. Vesicles 6:1347019. doi: 10.1080/20013078.2017.1347019
14. I.C.H. (2018). International Council for Harmonization. Available: http://www.ich.org/products/guidelines.html
15. Ibrahim, A. G., Cheng, K., and Marban, E. (2014). Exosomes as critical agents of cardiac regeneration triggered by cell therapy. Stem Cell Rep. 2, 606-619. doi: 10.1016/j.stemcr.2014.04.006
16. Kim, S. H., Lechman, E. R., Bianco, N., Menon, R., Keravala, A., Nash, J., et al. (2005). Exosomes derived from IL-10-treated dendritic cells can suppress inflammation and collagen-induced arthritis. J. Immunol. 174, 6440-6448. doi: 10.4049/jimmunol.174.10.6440
17. Konoshenko, M. Y., Lekchnov, E. A., Vlassov, A. V., and Laktionov, P. P. (2018). Isolation of extracellular vesicles: general methodologies and latest trends. Biomed Res. Int. 2018:8545347. doi: 10.1155/2018/8545347
18. Kowal, J., Arras, G., Colombo, M., Jouve, M., Morath, J. P., Primdal-Bengtson, B., et al. (2016). Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes. Proc. Natl. Acad. Sci. U.S.A. 113, E968-E977. doi: 10.1073/pnas.1521230113
19. Lamparski, H. G., Metha-Damani, A., Yao, J. Y., Patel, S., Hsu, D. H., Ruegg, C., et al. (2002). Production and characterization of clinical grade exosomes derived from dendritic cells. J. Immunol. Methods 270, 211-226. doi: 10.1016/S0022-1759(02)00330-7
20. Lener, T., Gimona, M., Aigner, L., Borger, V., Buzas, E., Camussi, G., et al. (2015). Applying extracellular vesicles based therapeutics in clinical trials-an ISEV position paper. J Extracell. Vesicles 4:30087. doi: 10.3402/jev.v4.30087
21. Makkar, R. R., Smith, R. R., Cheng, K., Malliaras, K., Thomson, L. E., Berman, D., et al. (2012). Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet 379, 895-904. doi: 10.1016/S0140-6736(12)60195-0
22. Malliaras, K., Makkar, R. R., Smith, R. R., Cheng, K., Wu, E., Bonow, R. O., et al. (2014). Intracoronary cardiosphere-derived cells after myocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction). J. Am. Coll. Cardiol. 63, 110-122. doi: 10.1016/j.jacc.2013.08.724
23. Monguio-Tortajada, M., Roura, S., Galvez-Monton, C., Pujal, J. M., Aran, G., Sanjurjo, L., et al. (2017). Nanosized UCMSC-derived extracellular vesicles but not conditioned medium exclusively inhibit the inflammatory response of stimulated T cells: implications for nanomedicine. Theranostics 7, 270-284. doi: 10.7150/thno.16154
24. Palpant, N. J., Pabon, L., Roberts, M., Hadland, B., Jones, D., Jones, C., et al. (2015). Inhibition of beta-catenin signaling respecifies anterior-like endothelium into beating human cardiomyocytes. Development 142, 3198-3209. doi: 10.1242/dev.117010
25. Pitt, J. M., Andre, F., Amigorena, S., Soria, J. C., Eggermont, A., Kroemer, G., et al. (2016). Dendritic cell-derived exosomes for cancer therapy. J. Clin. Invest. 126, 1224-1232. doi: 10.1172/JCI81137
26. Shedden, K., Xie, X. T., Chandaroy, P., Chang, Y. T., and Rosania, G. R. (2003). Expulsion of small molecules in vesicles shed by cancer cells: association with gene expression and chemosensitivity profiles. Cancer Res. 63, 4331-4337
27. Sluijter, J. P. G., Davidson, S. M., Boulanger, C. M., Buzas, E. I., De Kleijn, D. P. V., Engel, F. B., et al. (2018). Extracellular vesicles in diagnostics and therapy of the ischaemic heart: position paper from the working group on cellular biology of the heart of the european society of cardiology. Cardiovasc. Res. 114, 19-34. doi: 10.1093/cvr/cvx211
28. Solomon, J., Csontos, L., Clarke, D., Bonyhadi, M., Zylberberg, C., Mcniece, I., et al. (2016). Current perspectives on the use of ancillary materials for the manufacture of cellular therapies. Cytotherapy 18, 1-12. doi: 10.1016/j.jcyt.2015.09.010
29. Thery, C., Amigorena, S., Raposo, G., and Clayton, A. (2006). Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol 30, 3.22.1-3.22.29. doi: 10.1002/0471143030.cb0322s30
30. Van Niel, G., D'angelo, G., and Raposo, G. (2018). Shedding light on the cell biology of extracellular vesicles. Nat. Rev. Mol. Cell Biol. 19, 213-228. doi: 10.1038/nrm.2017.125
31. Witwer, K. W., Buzas, E. I., Bemis, L. T., Bora, A., Lasser, C., Lotvall, J., et al. (2013). Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J. Extracell. Vesicles 2, doi: 10.3402/jev.v2i0.20360
32. Xitong, D., and Xiaorong, Z. (2016). Targeted therapeutic delivery using engineered exosomes and its applications in cardiovascular diseases. Gene 575, 377-384. doi: 10.1016/j.gene.2015.08.067
33. Xu, J. Y., Chen, G. H., and Yang, Y. J. (2017). Exosomes: a rising star in falling hearts. Front. Physiol. 8:494. doi: 10.3389/fphys.2017.00494
34. Xu, R., Greening, D. W., Zhu, H. J., Takahashi, N., and Simpson, R. J. (2016). Extracellular vesicle isolation and characterization: toward clinical application. J Clin Invest 126, 1152-1162. doi: 10.1172/JCI81129